SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shukra Pharma gets Univlabs Technologies’ nod to sell laparoscopic sets in Gujarat

22 Dec 2025 Evaluate

Shukra Pharmaceuticals has received exclusive authorisation from Univlabs Technologies, an established and reputable manufacturer of Laparoscopic Sets. Under this authorisation, the company will sell the Laparoscopic Sets and accessories in the Government market of Gujarat. The authorisation is valid till March 2026.

Shukra Pharmaceuticals is an ambitious organisation with a deep-rooted focus on sustainability with its impressive range of solutions.

Shukra Pharma Share Price

30.65 0.21 (0.69%)
19-Jun-2026 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.20
Dr. Reddys Lab 1262.65
Cipla 1355.40
Zydus Lifesciences 1074.15
Lupin 2329.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: